August 29, 2024Advanced ScienceOpen Access

Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway

View Full Paper

Ask AI

Bookmark

Authors

ZLZihua LiTongji University HLHengli LuTongji University LFLimin FanTongji University

Discussion

Member takes

Implication

Preclinical study demonstrates cartilage preservation and bone regeneration in osteoarthritis models, highlighting a targeted microneedle therapeutic strategy.

Key Points

Microneedle-delivered polydopamine and exosomes prevent cartilage degradation and stimulate osteogenesis, while steering macrophage polarization toward an anti-inflammatory state.
RNA sequencing of treated chondrocytes demonstrates restored cellular function alongside antioxidant activation via the PI3K-AKT-mTOR pathway verified by Western blot analysis.
Supports disease-modifying osteoarthritis management with confirmed biocompatibility across organs—preclinical animal model; further clinical translation and validation are required.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e5a5e5b6db64358753fce1 https://doi.org/10.1002/advs.202406942

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study demonstrates cartilage preservation and bone regeneration in osteoarthritis models, highlighting a targeted microneedle therapeutic strategy.

Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway

Discussion

Member takes

Implication

Key Points

Cite This Study

Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider